nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—CYP2C9—Bexarotene—hematologic cancer	0.0661	0.191	CbGbCtD
Treprostinil—CYP2C9—Idarubicin—hematologic cancer	0.0547	0.159	CbGbCtD
Treprostinil—CYP2C9—Bortezomib—hematologic cancer	0.0405	0.117	CbGbCtD
Treprostinil—CYP2C9—Thalidomide—hematologic cancer	0.0353	0.102	CbGbCtD
Treprostinil—CYP2C9—Teniposide—hematologic cancer	0.0336	0.0975	CbGbCtD
Treprostinil—CYP2C9—Ifosfamide—hematologic cancer	0.0311	0.09	CbGbCtD
Treprostinil—CYP2C9—Imatinib—hematologic cancer	0.0297	0.0859	CbGbCtD
Treprostinil—CYP2C9—Nilotinib—hematologic cancer	0.027	0.0781	CbGbCtD
Treprostinil—CYP2C9—Cisplatin—hematologic cancer	0.0151	0.0438	CbGbCtD
Treprostinil—CYP2C9—Dexamethasone—hematologic cancer	0.0122	0.0354	CbGbCtD
Treprostinil—P2RY12—hematopoietic system—hematologic cancer	0.00863	0.15	CbGeAlD
Treprostinil—PPARD—hematopoietic system—hematologic cancer	0.00717	0.125	CbGeAlD
Treprostinil—P2RY12—blood—hematologic cancer	0.00572	0.0995	CbGeAlD
Treprostinil—PTGIR—hematopoietic system—hematologic cancer	0.00551	0.0958	CbGeAlD
Treprostinil—PTGIR—gonad—hematologic cancer	0.00419	0.0728	CbGeAlD
Treprostinil—PPARD—lung—hematologic cancer	0.00416	0.0725	CbGeAlD
Treprostinil—PPARD—testis—hematologic cancer	0.00393	0.0684	CbGeAlD
Treprostinil—PTGIR—blood—hematologic cancer	0.00365	0.0635	CbGeAlD
Treprostinil—PTGIR—lung—hematologic cancer	0.0032	0.0556	CbGeAlD
Treprostinil—PTGIR—testis—hematologic cancer	0.00302	0.0525	CbGeAlD
Treprostinil—PPARD—lymph node—hematologic cancer	0.00285	0.0496	CbGeAlD
Treprostinil—Latanoprost—SLC22A1—hematologic cancer	0.0024	0.812	CrCbGaD
Treprostinil—PTGIR—lymph node—hematologic cancer	0.00219	0.0381	CbGeAlD
Treprostinil—CYP2C9—hematopoietic system—hematologic cancer	0.00197	0.0342	CbGeAlD
Treprostinil—CYP2C9—blood—hematologic cancer	0.0013	0.0227	CbGeAlD
Treprostinil—Nadolol—ABCB1—hematologic cancer	0.000554	0.188	CrCbGaD
Treprostinil—Epistaxis—Doxorubicin—hematologic cancer	6.6e-05	0.000164	CcSEcCtD
Treprostinil—Vomiting—Irinotecan—hematologic cancer	6.58e-05	0.000163	CcSEcCtD
Treprostinil—Vomiting—Mitoxantrone—hematologic cancer	6.58e-05	0.000163	CcSEcCtD
Treprostinil—Sinusitis—Doxorubicin—hematologic cancer	6.57e-05	0.000163	CcSEcCtD
Treprostinil—Nausea—Alitretinoin—hematologic cancer	6.55e-05	0.000163	CcSEcCtD
Treprostinil—Rash—Mitoxantrone—hematologic cancer	6.52e-05	0.000162	CcSEcCtD
Treprostinil—Rash—Irinotecan—hematologic cancer	6.52e-05	0.000162	CcSEcCtD
Treprostinil—Dermatitis—Irinotecan—hematologic cancer	6.52e-05	0.000162	CcSEcCtD
Treprostinil—Dermatitis—Mitoxantrone—hematologic cancer	6.52e-05	0.000162	CcSEcCtD
Treprostinil—Headache—Irinotecan—hematologic cancer	6.48e-05	0.000161	CcSEcCtD
Treprostinil—Headache—Mitoxantrone—hematologic cancer	6.48e-05	0.000161	CcSEcCtD
Treprostinil—Nausea—Ifosfamide—hematologic cancer	6.47e-05	0.000161	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Betamethasone—hematologic cancer	6.45e-05	0.00016	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	6.45e-05	0.00016	CcSEcCtD
Treprostinil—Arthralgia—Prednisone—hematologic cancer	6.43e-05	0.00016	CcSEcCtD
Treprostinil—Myalgia—Prednisone—hematologic cancer	6.43e-05	0.00016	CcSEcCtD
Treprostinil—Feeling abnormal—Triamcinolone—hematologic cancer	6.43e-05	0.00016	CcSEcCtD
Treprostinil—Diarrhoea—Cisplatin—hematologic cancer	6.43e-05	0.00016	CcSEcCtD
Treprostinil—Anxiety—Prednisone—hematologic cancer	6.41e-05	0.000159	CcSEcCtD
Treprostinil—Vomiting—Gemcitabine—hematologic cancer	6.41e-05	0.000159	CcSEcCtD
Treprostinil—Insomnia—Betamethasone—hematologic cancer	6.41e-05	0.000159	CcSEcCtD
Treprostinil—Insomnia—Dexamethasone—hematologic cancer	6.41e-05	0.000159	CcSEcCtD
Treprostinil—Bradycardia—Doxorubicin—hematologic cancer	6.4e-05	0.000159	CcSEcCtD
Treprostinil—Paraesthesia—Dexamethasone—hematologic cancer	6.36e-05	0.000158	CcSEcCtD
Treprostinil—Paraesthesia—Betamethasone—hematologic cancer	6.36e-05	0.000158	CcSEcCtD
Treprostinil—Discomfort—Prednisone—hematologic cancer	6.36e-05	0.000158	CcSEcCtD
Treprostinil—Rash—Gemcitabine—hematologic cancer	6.35e-05	0.000158	CcSEcCtD
Treprostinil—Dermatitis—Gemcitabine—hematologic cancer	6.35e-05	0.000158	CcSEcCtD
Treprostinil—Erythema—Methotrexate—hematologic cancer	6.32e-05	0.000157	CcSEcCtD
Treprostinil—Haemoglobin—Doxorubicin—hematologic cancer	6.31e-05	0.000157	CcSEcCtD
Treprostinil—Headache—Gemcitabine—hematologic cancer	6.31e-05	0.000157	CcSEcCtD
Treprostinil—Nausea—Vincristine—hematologic cancer	6.31e-05	0.000157	CcSEcCtD
Treprostinil—Flushing—Epirubicin—hematologic cancer	6.3e-05	0.000157	CcSEcCtD
Treprostinil—Rhinitis—Doxorubicin—hematologic cancer	6.3e-05	0.000157	CcSEcCtD
Treprostinil—Haemorrhage—Doxorubicin—hematologic cancer	6.28e-05	0.000156	CcSEcCtD
Treprostinil—Pharyngitis—Doxorubicin—hematologic cancer	6.24e-05	0.000155	CcSEcCtD
Treprostinil—Dyspepsia—Dexamethasone—hematologic cancer	6.23e-05	0.000155	CcSEcCtD
Treprostinil—Dyspepsia—Betamethasone—hematologic cancer	6.23e-05	0.000155	CcSEcCtD
Treprostinil—Oedema peripheral—Doxorubicin—hematologic cancer	6.19e-05	0.000154	CcSEcCtD
Treprostinil—Asthenia—Etoposide—hematologic cancer	6.17e-05	0.000153	CcSEcCtD
Treprostinil—Body temperature increased—Triamcinolone—hematologic cancer	6.17e-05	0.000153	CcSEcCtD
Treprostinil—Oedema—Prednisone—hematologic cancer	6.17e-05	0.000153	CcSEcCtD
Treprostinil—Decreased appetite—Dexamethasone—hematologic cancer	6.16e-05	0.000153	CcSEcCtD
Treprostinil—Decreased appetite—Betamethasone—hematologic cancer	6.16e-05	0.000153	CcSEcCtD
Treprostinil—Nausea—Mitoxantrone—hematologic cancer	6.15e-05	0.000153	CcSEcCtD
Treprostinil—Nausea—Irinotecan—hematologic cancer	6.15e-05	0.000153	CcSEcCtD
Treprostinil—Infection—Prednisone—hematologic cancer	6.13e-05	0.000152	CcSEcCtD
Treprostinil—Back pain—Methotrexate—hematologic cancer	6.11e-05	0.000152	CcSEcCtD
Treprostinil—Fatigue—Dexamethasone—hematologic cancer	6.11e-05	0.000152	CcSEcCtD
Treprostinil—Fatigue—Betamethasone—hematologic cancer	6.11e-05	0.000152	CcSEcCtD
Treprostinil—Pruritus—Etoposide—hematologic cancer	6.09e-05	0.000151	CcSEcCtD
Treprostinil—Shock—Prednisone—hematologic cancer	6.07e-05	0.000151	CcSEcCtD
Treprostinil—Pain—Betamethasone—hematologic cancer	6.06e-05	0.000151	CcSEcCtD
Treprostinil—Pain—Dexamethasone—hematologic cancer	6.06e-05	0.000151	CcSEcCtD
Treprostinil—Tachycardia—Prednisone—hematologic cancer	6.02e-05	0.00015	CcSEcCtD
Treprostinil—Nausea—Gemcitabine—hematologic cancer	5.99e-05	0.000149	CcSEcCtD
Treprostinil—Vomiting—Cisplatin—hematologic cancer	5.97e-05	0.000148	CcSEcCtD
Treprostinil—Rash—Cisplatin—hematologic cancer	5.92e-05	0.000147	CcSEcCtD
Treprostinil—Dermatitis—Cisplatin—hematologic cancer	5.92e-05	0.000147	CcSEcCtD
Treprostinil—Erythema—Epirubicin—hematologic cancer	5.91e-05	0.000147	CcSEcCtD
Treprostinil—Diarrhoea—Etoposide—hematologic cancer	5.89e-05	0.000146	CcSEcCtD
Treprostinil—Anorexia—Prednisone—hematologic cancer	5.88e-05	0.000146	CcSEcCtD
Treprostinil—Ill-defined disorder—Methotrexate—hematologic cancer	5.86e-05	0.000146	CcSEcCtD
Treprostinil—Anaemia—Methotrexate—hematologic cancer	5.84e-05	0.000145	CcSEcCtD
Treprostinil—Feeling abnormal—Dexamethasone—hematologic cancer	5.84e-05	0.000145	CcSEcCtD
Treprostinil—Feeling abnormal—Betamethasone—hematologic cancer	5.84e-05	0.000145	CcSEcCtD
Treprostinil—Flushing—Doxorubicin—hematologic cancer	5.83e-05	0.000145	CcSEcCtD
Treprostinil—Tension—Epirubicin—hematologic cancer	5.8e-05	0.000144	CcSEcCtD
Treprostinil—Gastrointestinal pain—Betamethasone—hematologic cancer	5.79e-05	0.000144	CcSEcCtD
Treprostinil—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.79e-05	0.000144	CcSEcCtD
Treprostinil—Nervousness—Epirubicin—hematologic cancer	5.74e-05	0.000143	CcSEcCtD
Treprostinil—Back pain—Epirubicin—hematologic cancer	5.72e-05	0.000142	CcSEcCtD
Treprostinil—Malaise—Methotrexate—hematologic cancer	5.7e-05	0.000142	CcSEcCtD
Treprostinil—Dizziness—Etoposide—hematologic cancer	5.69e-05	0.000141	CcSEcCtD
Treprostinil—Muscle spasms—Epirubicin—hematologic cancer	5.68e-05	0.000141	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.62e-05	0.00014	CcSEcCtD
Treprostinil—Dizziness—Prednisolone—hematologic cancer	5.61e-05	0.00014	CcSEcCtD
Treprostinil—Asthenia—Triamcinolone—hematologic cancer	5.6e-05	0.000139	CcSEcCtD
Treprostinil—Abdominal pain—Dexamethasone—hematologic cancer	5.6e-05	0.000139	CcSEcCtD
Treprostinil—Abdominal pain—Betamethasone—hematologic cancer	5.6e-05	0.000139	CcSEcCtD
Treprostinil—Body temperature increased—Dexamethasone—hematologic cancer	5.6e-05	0.000139	CcSEcCtD
Treprostinil—Body temperature increased—Betamethasone—hematologic cancer	5.6e-05	0.000139	CcSEcCtD
Treprostinil—Nausea—Cisplatin—hematologic cancer	5.58e-05	0.000139	CcSEcCtD
Treprostinil—Insomnia—Prednisone—hematologic cancer	5.58e-05	0.000139	CcSEcCtD
Treprostinil—Paraesthesia—Prednisone—hematologic cancer	5.54e-05	0.000138	CcSEcCtD
Treprostinil—Pruritus—Triamcinolone—hematologic cancer	5.52e-05	0.000137	CcSEcCtD
Treprostinil—Cough—Methotrexate—hematologic cancer	5.51e-05	0.000137	CcSEcCtD
Treprostinil—Ill-defined disorder—Epirubicin—hematologic cancer	5.48e-05	0.000136	CcSEcCtD
Treprostinil—Vomiting—Etoposide—hematologic cancer	5.47e-05	0.000136	CcSEcCtD
Treprostinil—Erythema—Doxorubicin—hematologic cancer	5.47e-05	0.000136	CcSEcCtD
Treprostinil—Anaemia—Epirubicin—hematologic cancer	5.46e-05	0.000136	CcSEcCtD
Treprostinil—Dyspepsia—Prednisone—hematologic cancer	5.43e-05	0.000135	CcSEcCtD
Treprostinil—Rash—Etoposide—hematologic cancer	5.43e-05	0.000135	CcSEcCtD
Treprostinil—Dermatitis—Etoposide—hematologic cancer	5.42e-05	0.000135	CcSEcCtD
Treprostinil—Headache—Etoposide—hematologic cancer	5.39e-05	0.000134	CcSEcCtD
Treprostinil—Myalgia—Methotrexate—hematologic cancer	5.38e-05	0.000134	CcSEcCtD
Treprostinil—Chest pain—Methotrexate—hematologic cancer	5.38e-05	0.000134	CcSEcCtD
Treprostinil—Arthralgia—Methotrexate—hematologic cancer	5.38e-05	0.000134	CcSEcCtD
Treprostinil—Tension—Doxorubicin—hematologic cancer	5.37e-05	0.000133	CcSEcCtD
Treprostinil—Decreased appetite—Prednisone—hematologic cancer	5.36e-05	0.000133	CcSEcCtD
Treprostinil—Rash—Prednisolone—hematologic cancer	5.35e-05	0.000133	CcSEcCtD
Treprostinil—Dermatitis—Prednisolone—hematologic cancer	5.35e-05	0.000133	CcSEcCtD
Treprostinil—Malaise—Epirubicin—hematologic cancer	5.33e-05	0.000132	CcSEcCtD
Treprostinil—Fatigue—Prednisone—hematologic cancer	5.32e-05	0.000132	CcSEcCtD
Treprostinil—Headache—Prednisolone—hematologic cancer	5.32e-05	0.000132	CcSEcCtD
Treprostinil—Discomfort—Methotrexate—hematologic cancer	5.31e-05	0.000132	CcSEcCtD
Treprostinil—Nervousness—Doxorubicin—hematologic cancer	5.31e-05	0.000132	CcSEcCtD
Treprostinil—Syncope—Epirubicin—hematologic cancer	5.3e-05	0.000132	CcSEcCtD
Treprostinil—Back pain—Doxorubicin—hematologic cancer	5.29e-05	0.000131	CcSEcCtD
Treprostinil—Muscle spasms—Doxorubicin—hematologic cancer	5.26e-05	0.000131	CcSEcCtD
Treprostinil—Palpitations—Epirubicin—hematologic cancer	5.22e-05	0.00013	CcSEcCtD
Treprostinil—Loss of consciousness—Epirubicin—hematologic cancer	5.19e-05	0.000129	CcSEcCtD
Treprostinil—Dizziness—Triamcinolone—hematologic cancer	5.16e-05	0.000128	CcSEcCtD
Treprostinil—Cough—Epirubicin—hematologic cancer	5.16e-05	0.000128	CcSEcCtD
Treprostinil—Infection—Methotrexate—hematologic cancer	5.12e-05	0.000127	CcSEcCtD
Treprostinil—Nausea—Etoposide—hematologic cancer	5.11e-05	0.000127	CcSEcCtD
Treprostinil—Feeling abnormal—Prednisone—hematologic cancer	5.08e-05	0.000126	CcSEcCtD
Treprostinil—Asthenia—Dexamethasone—hematologic cancer	5.08e-05	0.000126	CcSEcCtD
Treprostinil—Asthenia—Betamethasone—hematologic cancer	5.08e-05	0.000126	CcSEcCtD
Treprostinil—Ill-defined disorder—Doxorubicin—hematologic cancer	5.07e-05	0.000126	CcSEcCtD
Treprostinil—Anaemia—Doxorubicin—hematologic cancer	5.05e-05	0.000126	CcSEcCtD
Treprostinil—Thrombocytopenia—Methotrexate—hematologic cancer	5.05e-05	0.000125	CcSEcCtD
Treprostinil—Gastrointestinal pain—Prednisone—hematologic cancer	5.04e-05	0.000125	CcSEcCtD
Treprostinil—Nausea—Prednisolone—hematologic cancer	5.04e-05	0.000125	CcSEcCtD
Treprostinil—Chest pain—Epirubicin—hematologic cancer	5.03e-05	0.000125	CcSEcCtD
Treprostinil—Myalgia—Epirubicin—hematologic cancer	5.03e-05	0.000125	CcSEcCtD
Treprostinil—Arthralgia—Epirubicin—hematologic cancer	5.03e-05	0.000125	CcSEcCtD
Treprostinil—Anxiety—Epirubicin—hematologic cancer	5.01e-05	0.000125	CcSEcCtD
Treprostinil—Pruritus—Dexamethasone—hematologic cancer	5.01e-05	0.000125	CcSEcCtD
Treprostinil—Pruritus—Betamethasone—hematologic cancer	5.01e-05	0.000125	CcSEcCtD
Treprostinil—Discomfort—Epirubicin—hematologic cancer	4.97e-05	0.000124	CcSEcCtD
Treprostinil—Vomiting—Triamcinolone—hematologic cancer	4.96e-05	0.000123	CcSEcCtD
Treprostinil—Malaise—Doxorubicin—hematologic cancer	4.93e-05	0.000123	CcSEcCtD
Treprostinil—Rash—Triamcinolone—hematologic cancer	4.92e-05	0.000122	CcSEcCtD
Treprostinil—Dermatitis—Triamcinolone—hematologic cancer	4.92e-05	0.000122	CcSEcCtD
Treprostinil—Anorexia—Methotrexate—hematologic cancer	4.91e-05	0.000122	CcSEcCtD
Treprostinil—Syncope—Doxorubicin—hematologic cancer	4.9e-05	0.000122	CcSEcCtD
Treprostinil—Headache—Triamcinolone—hematologic cancer	4.89e-05	0.000122	CcSEcCtD
Treprostinil—Abdominal pain—Prednisone—hematologic cancer	4.88e-05	0.000121	CcSEcCtD
Treprostinil—Body temperature increased—Prednisone—hematologic cancer	4.88e-05	0.000121	CcSEcCtD
Treprostinil—Diarrhoea—Betamethasone—hematologic cancer	4.85e-05	0.00012	CcSEcCtD
Treprostinil—Diarrhoea—Dexamethasone—hematologic cancer	4.85e-05	0.00012	CcSEcCtD
Treprostinil—Palpitations—Doxorubicin—hematologic cancer	4.83e-05	0.00012	CcSEcCtD
Treprostinil—Oedema—Epirubicin—hematologic cancer	4.82e-05	0.00012	CcSEcCtD
Treprostinil—Hypotension—Methotrexate—hematologic cancer	4.82e-05	0.00012	CcSEcCtD
Treprostinil—Loss of consciousness—Doxorubicin—hematologic cancer	4.81e-05	0.000119	CcSEcCtD
Treprostinil—Infection—Epirubicin—hematologic cancer	4.79e-05	0.000119	CcSEcCtD
Treprostinil—Cough—Doxorubicin—hematologic cancer	4.77e-05	0.000119	CcSEcCtD
Treprostinil—Shock—Epirubicin—hematologic cancer	4.75e-05	0.000118	CcSEcCtD
Treprostinil—Thrombocytopenia—Epirubicin—hematologic cancer	4.72e-05	0.000117	CcSEcCtD
Treprostinil—Tachycardia—Epirubicin—hematologic cancer	4.71e-05	0.000117	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.7e-05	0.000117	CcSEcCtD
Treprostinil—Dizziness—Dexamethasone—hematologic cancer	4.68e-05	0.000116	CcSEcCtD
Treprostinil—Dizziness—Betamethasone—hematologic cancer	4.68e-05	0.000116	CcSEcCtD
Treprostinil—Insomnia—Methotrexate—hematologic cancer	4.66e-05	0.000116	CcSEcCtD
Treprostinil—Chest pain—Doxorubicin—hematologic cancer	4.66e-05	0.000116	CcSEcCtD
Treprostinil—Arthralgia—Doxorubicin—hematologic cancer	4.66e-05	0.000116	CcSEcCtD
Treprostinil—Myalgia—Doxorubicin—hematologic cancer	4.66e-05	0.000116	CcSEcCtD
Treprostinil—Anxiety—Doxorubicin—hematologic cancer	4.64e-05	0.000115	CcSEcCtD
Treprostinil—Nausea—Triamcinolone—hematologic cancer	4.64e-05	0.000115	CcSEcCtD
Treprostinil—Paraesthesia—Methotrexate—hematologic cancer	4.63e-05	0.000115	CcSEcCtD
Treprostinil—Discomfort—Doxorubicin—hematologic cancer	4.6e-05	0.000114	CcSEcCtD
Treprostinil—Anorexia—Epirubicin—hematologic cancer	4.6e-05	0.000114	CcSEcCtD
Treprostinil—Dyspnoea—Methotrexate—hematologic cancer	4.6e-05	0.000114	CcSEcCtD
Treprostinil—Dyspepsia—Methotrexate—hematologic cancer	4.54e-05	0.000113	CcSEcCtD
Treprostinil—Hypotension—Epirubicin—hematologic cancer	4.51e-05	0.000112	CcSEcCtD
Treprostinil—Vomiting—Dexamethasone—hematologic cancer	4.5e-05	0.000112	CcSEcCtD
Treprostinil—Vomiting—Betamethasone—hematologic cancer	4.5e-05	0.000112	CcSEcCtD
Treprostinil—Decreased appetite—Methotrexate—hematologic cancer	4.48e-05	0.000111	CcSEcCtD
Treprostinil—Rash—Dexamethasone—hematologic cancer	4.47e-05	0.000111	CcSEcCtD
Treprostinil—Rash—Betamethasone—hematologic cancer	4.47e-05	0.000111	CcSEcCtD
Treprostinil—Oedema—Doxorubicin—hematologic cancer	4.46e-05	0.000111	CcSEcCtD
Treprostinil—Dermatitis—Betamethasone—hematologic cancer	4.46e-05	0.000111	CcSEcCtD
Treprostinil—Dermatitis—Dexamethasone—hematologic cancer	4.46e-05	0.000111	CcSEcCtD
Treprostinil—Fatigue—Methotrexate—hematologic cancer	4.44e-05	0.00011	CcSEcCtD
Treprostinil—Headache—Dexamethasone—hematologic cancer	4.44e-05	0.00011	CcSEcCtD
Treprostinil—Headache—Betamethasone—hematologic cancer	4.44e-05	0.00011	CcSEcCtD
Treprostinil—Infection—Doxorubicin—hematologic cancer	4.43e-05	0.00011	CcSEcCtD
Treprostinil—Asthenia—Prednisone—hematologic cancer	4.43e-05	0.00011	CcSEcCtD
Treprostinil—Pain—Methotrexate—hematologic cancer	4.41e-05	0.00011	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.39e-05	0.000109	CcSEcCtD
Treprostinil—Shock—Doxorubicin—hematologic cancer	4.39e-05	0.000109	CcSEcCtD
Treprostinil—Thrombocytopenia—Doxorubicin—hematologic cancer	4.37e-05	0.000109	CcSEcCtD
Treprostinil—Pruritus—Prednisone—hematologic cancer	4.36e-05	0.000108	CcSEcCtD
Treprostinil—Insomnia—Epirubicin—hematologic cancer	4.36e-05	0.000108	CcSEcCtD
Treprostinil—Tachycardia—Doxorubicin—hematologic cancer	4.36e-05	0.000108	CcSEcCtD
Treprostinil—Paraesthesia—Epirubicin—hematologic cancer	4.33e-05	0.000108	CcSEcCtD
Treprostinil—Dyspnoea—Epirubicin—hematologic cancer	4.3e-05	0.000107	CcSEcCtD
Treprostinil—Anorexia—Doxorubicin—hematologic cancer	4.25e-05	0.000106	CcSEcCtD
Treprostinil—Feeling abnormal—Methotrexate—hematologic cancer	4.25e-05	0.000106	CcSEcCtD
Treprostinil—Dyspepsia—Epirubicin—hematologic cancer	4.25e-05	0.000106	CcSEcCtD
Treprostinil—Diarrhoea—Prednisone—hematologic cancer	4.22e-05	0.000105	CcSEcCtD
Treprostinil—Gastrointestinal pain—Methotrexate—hematologic cancer	4.21e-05	0.000105	CcSEcCtD
Treprostinil—Nausea—Dexamethasone—hematologic cancer	4.21e-05	0.000105	CcSEcCtD
Treprostinil—Nausea—Betamethasone—hematologic cancer	4.21e-05	0.000105	CcSEcCtD
Treprostinil—Decreased appetite—Epirubicin—hematologic cancer	4.19e-05	0.000104	CcSEcCtD
Treprostinil—Hypotension—Doxorubicin—hematologic cancer	4.17e-05	0.000104	CcSEcCtD
Treprostinil—Fatigue—Epirubicin—hematologic cancer	4.16e-05	0.000103	CcSEcCtD
Treprostinil—Pain—Epirubicin—hematologic cancer	4.13e-05	0.000103	CcSEcCtD
Treprostinil—Dizziness—Prednisone—hematologic cancer	4.08e-05	0.000101	CcSEcCtD
Treprostinil—Body temperature increased—Methotrexate—hematologic cancer	4.07e-05	0.000101	CcSEcCtD
Treprostinil—Abdominal pain—Methotrexate—hematologic cancer	4.07e-05	0.000101	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.07e-05	0.000101	CcSEcCtD
Treprostinil—Insomnia—Doxorubicin—hematologic cancer	4.04e-05	0.0001	CcSEcCtD
Treprostinil—Paraesthesia—Doxorubicin—hematologic cancer	4.01e-05	9.96e-05	CcSEcCtD
Treprostinil—Dyspnoea—Doxorubicin—hematologic cancer	3.98e-05	9.89e-05	CcSEcCtD
Treprostinil—Feeling abnormal—Epirubicin—hematologic cancer	3.98e-05	9.88e-05	CcSEcCtD
Treprostinil—Gastrointestinal pain—Epirubicin—hematologic cancer	3.94e-05	9.8e-05	CcSEcCtD
Treprostinil—Dyspepsia—Doxorubicin—hematologic cancer	3.93e-05	9.77e-05	CcSEcCtD
Treprostinil—Vomiting—Prednisone—hematologic cancer	3.92e-05	9.75e-05	CcSEcCtD
Treprostinil—Rash—Prednisone—hematologic cancer	3.89e-05	9.67e-05	CcSEcCtD
Treprostinil—Dermatitis—Prednisone—hematologic cancer	3.89e-05	9.66e-05	CcSEcCtD
Treprostinil—Decreased appetite—Doxorubicin—hematologic cancer	3.88e-05	9.64e-05	CcSEcCtD
Treprostinil—Headache—Prednisone—hematologic cancer	3.86e-05	9.6e-05	CcSEcCtD
Treprostinil—Fatigue—Doxorubicin—hematologic cancer	3.85e-05	9.56e-05	CcSEcCtD
Treprostinil—Pain—Doxorubicin—hematologic cancer	3.82e-05	9.49e-05	CcSEcCtD
Treprostinil—Body temperature increased—Epirubicin—hematologic cancer	3.81e-05	9.48e-05	CcSEcCtD
Treprostinil—Abdominal pain—Epirubicin—hematologic cancer	3.81e-05	9.48e-05	CcSEcCtD
Treprostinil—Asthenia—Methotrexate—hematologic cancer	3.7e-05	9.19e-05	CcSEcCtD
Treprostinil—Feeling abnormal—Doxorubicin—hematologic cancer	3.68e-05	9.14e-05	CcSEcCtD
Treprostinil—Nausea—Prednisone—hematologic cancer	3.66e-05	9.11e-05	CcSEcCtD
Treprostinil—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.65e-05	9.07e-05	CcSEcCtD
Treprostinil—Pruritus—Methotrexate—hematologic cancer	3.65e-05	9.06e-05	CcSEcCtD
Treprostinil—Abdominal pain—Doxorubicin—hematologic cancer	3.53e-05	8.77e-05	CcSEcCtD
Treprostinil—Body temperature increased—Doxorubicin—hematologic cancer	3.53e-05	8.77e-05	CcSEcCtD
Treprostinil—Diarrhoea—Methotrexate—hematologic cancer	3.53e-05	8.77e-05	CcSEcCtD
Treprostinil—Asthenia—Epirubicin—hematologic cancer	3.46e-05	8.6e-05	CcSEcCtD
Treprostinil—Pruritus—Epirubicin—hematologic cancer	3.41e-05	8.48e-05	CcSEcCtD
Treprostinil—Dizziness—Methotrexate—hematologic cancer	3.41e-05	8.47e-05	CcSEcCtD
Treprostinil—Diarrhoea—Epirubicin—hematologic cancer	3.3e-05	8.2e-05	CcSEcCtD
Treprostinil—Vomiting—Methotrexate—hematologic cancer	3.28e-05	8.15e-05	CcSEcCtD
Treprostinil—Rash—Methotrexate—hematologic cancer	3.25e-05	8.08e-05	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3R1—hematologic cancer	3.25e-05	0.000169	CbGpPWpGaD
Treprostinil—Dermatitis—Methotrexate—hematologic cancer	3.25e-05	8.07e-05	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—CDKN2B—hematologic cancer	3.24e-05	0.000169	CbGpPWpGaD
Treprostinil—Headache—Methotrexate—hematologic cancer	3.23e-05	8.03e-05	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—PIK3R1—hematologic cancer	3.21e-05	0.000167	CbGpPWpGaD
Treprostinil—Asthenia—Doxorubicin—hematologic cancer	3.2e-05	7.96e-05	CcSEcCtD
Treprostinil—Dizziness—Epirubicin—hematologic cancer	3.19e-05	7.93e-05	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—JAK2—hematologic cancer	3.16e-05	0.000164	CbGpPWpGaD
Treprostinil—Pruritus—Doxorubicin—hematologic cancer	3.16e-05	7.85e-05	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—KRAS—hematologic cancer	3.15e-05	0.000164	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MAP2K1—hematologic cancer	3.15e-05	0.000164	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PIK3CA—hematologic cancer	3.14e-05	0.000164	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CD86—hematologic cancer	3.13e-05	0.000163	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GRB2—hematologic cancer	3.13e-05	0.000163	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CD—hematologic cancer	3.12e-05	0.000163	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PDGFA—hematologic cancer	3.12e-05	0.000163	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—JAK2—hematologic cancer	3.12e-05	0.000162	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	3.1e-05	0.000162	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HES1—hematologic cancer	3.09e-05	0.000161	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KITLG—hematologic cancer	3.08e-05	0.00016	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NCOR1—hematologic cancer	3.07e-05	0.00016	CbGpPWpGaD
Treprostinil—Vomiting—Epirubicin—hematologic cancer	3.07e-05	7.62e-05	CcSEcCtD
Treprostinil—Nausea—Methotrexate—hematologic cancer	3.06e-05	7.61e-05	CcSEcCtD
Treprostinil—Diarrhoea—Doxorubicin—hematologic cancer	3.05e-05	7.59e-05	CcSEcCtD
Treprostinil—Rash—Epirubicin—hematologic cancer	3.04e-05	7.56e-05	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—TP53—hematologic cancer	3.04e-05	0.000158	CbGpPWpGaD
Treprostinil—Dermatitis—Epirubicin—hematologic cancer	3.04e-05	7.55e-05	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—CSF2—hematologic cancer	3.04e-05	0.000158	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FGF1—hematologic cancer	3.04e-05	0.000158	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	3.03e-05	0.000158	CbGpPWpGaD
Treprostinil—Headache—Epirubicin—hematologic cancer	3.02e-05	7.51e-05	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—STAT5A—hematologic cancer	3.01e-05	0.000157	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CB—hematologic cancer	3e-05	0.000156	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FOXO1—hematologic cancer	2.99e-05	0.000156	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—IL2—hematologic cancer	2.99e-05	0.000156	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PDGFRB—hematologic cancer	2.99e-05	0.000156	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN2B—hematologic cancer	2.98e-05	0.000155	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CB—hematologic cancer	2.96e-05	0.000154	CbGpPWpGaD
Treprostinil—Dizziness—Doxorubicin—hematologic cancer	2.95e-05	7.34e-05	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—PIK3R1—hematologic cancer	2.95e-05	0.000154	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PDGFRA—hematologic cancer	2.94e-05	0.000153	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PRKCG—hematologic cancer	2.93e-05	0.000153	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—JAK1—hematologic cancer	2.93e-05	0.000153	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ASNS—hematologic cancer	2.91e-05	0.000152	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—DCK—hematologic cancer	2.91e-05	0.000152	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—B3GAT1—hematologic cancer	2.91e-05	0.000152	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—HRAS—hematologic cancer	2.91e-05	0.000151	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PIK3CA—hematologic cancer	2.89e-05	0.000151	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.89e-05	0.000151	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CD86—hematologic cancer	2.88e-05	0.00015	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—JAK2—hematologic cancer	2.87e-05	0.000149	CbGpPWpGaD
Treprostinil—Nausea—Epirubicin—hematologic cancer	2.87e-05	7.12e-05	CcSEcCtD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.84e-05	0.000148	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HES1—hematologic cancer	2.84e-05	0.000148	CbGpPWpGaD
Treprostinil—Vomiting—Doxorubicin—hematologic cancer	2.84e-05	7.05e-05	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—NCOR1—hematologic cancer	2.83e-05	0.000147	CbGpPWpGaD
Treprostinil—Rash—Doxorubicin—hematologic cancer	2.81e-05	6.99e-05	CcSEcCtD
Treprostinil—Dermatitis—Doxorubicin—hematologic cancer	2.81e-05	6.99e-05	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—TP53—hematologic cancer	2.8e-05	0.000146	CbGpPWpGaD
Treprostinil—Headache—Doxorubicin—hematologic cancer	2.8e-05	6.95e-05	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—CSF2—hematologic cancer	2.8e-05	0.000146	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FGF1—hematologic cancer	2.8e-05	0.000146	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HDC—hematologic cancer	2.76e-05	0.000144	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CG—hematologic cancer	2.76e-05	0.000144	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FOXO1—hematologic cancer	2.76e-05	0.000143	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—IL2—hematologic cancer	2.75e-05	0.000143	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PDGFRB—hematologic cancer	2.75e-05	0.000143	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL2RA—hematologic cancer	2.74e-05	0.000143	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CB—hematologic cancer	2.72e-05	0.000142	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL2—hematologic cancer	2.72e-05	0.000141	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PDGFRA—hematologic cancer	2.71e-05	0.000141	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TERT—hematologic cancer	2.71e-05	0.000141	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JAK1—hematologic cancer	2.7e-05	0.00014	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PRKCG—hematologic cancer	2.7e-05	0.00014	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—HRAS—hematologic cancer	2.68e-05	0.000139	CbGpPWpGaD
Treprostinil—Nausea—Doxorubicin—hematologic cancer	2.65e-05	6.59e-05	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—PDGFB—hematologic cancer	2.64e-05	0.000138	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TSC2—hematologic cancer	2.58e-05	0.000134	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.57e-05	0.000134	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—AKT1—hematologic cancer	2.57e-05	0.000134	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CREBBP—hematologic cancer	2.56e-05	0.000133	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CDA—hematologic cancer	2.52e-05	0.000131	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL2RA—hematologic cancer	2.52e-05	0.000131	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL2—hematologic cancer	2.5e-05	0.00013	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TERT—hematologic cancer	2.49e-05	0.00013	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FGFR3—hematologic cancer	2.49e-05	0.000129	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK14—hematologic cancer	2.46e-05	0.000128	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PDGFB—hematologic cancer	2.43e-05	0.000127	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PC—hematologic cancer	2.43e-05	0.000126	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CD—hematologic cancer	2.42e-05	0.000126	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ESR1—hematologic cancer	2.41e-05	0.000126	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ALB—hematologic cancer	2.39e-05	0.000125	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FN1—hematologic cancer	2.38e-05	0.000124	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TSC2—hematologic cancer	2.38e-05	0.000124	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—AKT1—hematologic cancer	2.36e-05	0.000123	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—BAD—hematologic cancer	2.36e-05	0.000123	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NFKBIA—hematologic cancer	2.36e-05	0.000123	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GBA—hematologic cancer	2.35e-05	0.000122	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC35B2—hematologic cancer	2.35e-05	0.000122	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NOTCH1—hematologic cancer	2.33e-05	0.000121	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3R1—hematologic cancer	2.29e-05	0.000119	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FGFR3—hematologic cancer	2.29e-05	0.000119	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CD80—hematologic cancer	2.29e-05	0.000119	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CG—hematologic cancer	2.28e-05	0.000119	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KIT—hematologic cancer	2.28e-05	0.000119	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—NRAS—hematologic cancer	2.28e-05	0.000119	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK14—hematologic cancer	2.26e-05	0.000118	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTPN11—hematologic cancer	2.24e-05	0.000117	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ESR1—hematologic cancer	2.22e-05	0.000116	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FN1—hematologic cancer	2.19e-05	0.000114	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—MAPK3—hematologic cancer	2.19e-05	0.000114	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CREB1—hematologic cancer	2.17e-05	0.000113	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—BAD—hematologic cancer	2.17e-05	0.000113	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NFKBIA—hematologic cancer	2.17e-05	0.000113	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NOTCH1—hematologic cancer	2.15e-05	0.000112	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MTAP—hematologic cancer	2.15e-05	0.000112	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—BRAF—hematologic cancer	2.14e-05	0.000112	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL2—hematologic cancer	2.12e-05	0.000111	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6R—hematologic cancer	2.12e-05	0.00011	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CREBBP—hematologic cancer	2.12e-05	0.00011	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CB—hematologic cancer	2.11e-05	0.00011	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CD80—hematologic cancer	2.1e-05	0.00011	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CG—hematologic cancer	2.1e-05	0.000109	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KIT—hematologic cancer	2.1e-05	0.000109	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—NRAS—hematologic cancer	2.1e-05	0.000109	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTPN11—hematologic cancer	2.06e-05	0.000107	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAP2K1—hematologic cancer	2.02e-05	0.000105	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MAPK3—hematologic cancer	2.01e-05	0.000105	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MAPK3—hematologic cancer	2.01e-05	0.000104	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CD—hematologic cancer	2.01e-05	0.000104	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CREB1—hematologic cancer	2e-05	0.000104	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CA—hematologic cancer	1.99e-05	0.000103	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—BRAF—hematologic cancer	1.97e-05	0.000103	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—KRAS—hematologic cancer	1.96e-05	0.000102	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL2—hematologic cancer	1.96e-05	0.000102	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MYC—hematologic cancer	1.95e-05	0.000102	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6R—hematologic cancer	1.95e-05	0.000102	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CREBBP—hematologic cancer	1.95e-05	0.000101	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FGF2—hematologic cancer	1.92e-05	0.0001	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—FHL2—hematologic cancer	1.91e-05	9.96e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3R1—hematologic cancer	1.89e-05	9.86e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AGRN—hematologic cancer	1.88e-05	9.76e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAP2K1—hematologic cancer	1.86e-05	9.67e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CD—hematologic cancer	1.85e-05	9.61e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—JAK2—hematologic cancer	1.84e-05	9.58e-05	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CA—hematologic cancer	1.83e-05	9.52e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTEN—hematologic cancer	1.83e-05	9.5e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—KRAS—hematologic cancer	1.81e-05	9.41e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CA—hematologic cancer	1.8e-05	9.39e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MDM2—hematologic cancer	1.8e-05	9.35e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—IDH2—hematologic cancer	1.78e-05	9.26e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HMMR—hematologic cancer	1.78e-05	9.26e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FGF2—hematologic cancer	1.77e-05	9.2e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MTOR—hematologic cancer	1.75e-05	9.1e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CB—hematologic cancer	1.75e-05	9.1e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3R1—hematologic cancer	1.74e-05	9.07e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—EP300—hematologic cancer	1.74e-05	9.06e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JAK2—hematologic cancer	1.69e-05	8.82e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.68e-05	8.73e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ARNTL—hematologic cancer	1.67e-05	8.7e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—HRAS—hematologic cancer	1.67e-05	8.69e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CA—hematologic cancer	1.66e-05	8.64e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MDM2—hematologic cancer	1.65e-05	8.61e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDKN1B—hematologic cancer	1.64e-05	8.54e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CA9—hematologic cancer	1.63e-05	8.47e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ACP5—hematologic cancer	1.63e-05	8.47e-05	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AKT1—hematologic cancer	1.62e-05	8.45e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MTOR—hematologic cancer	1.61e-05	8.38e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CB—hematologic cancer	1.61e-05	8.38e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CASP3—hematologic cancer	1.61e-05	8.37e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL2—hematologic cancer	1.61e-05	8.36e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NCOR2—hematologic cancer	1.6e-05	8.35e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—hematologic cancer	1.6e-05	8.32e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCND1—hematologic cancer	1.57e-05	8.15e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—JUN—hematologic cancer	1.56e-05	8.13e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—HRAS—hematologic cancer	1.54e-05	8e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—IDH1—hematologic cancer	1.53e-05	7.96e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDKN1A—hematologic cancer	1.51e-05	7.88e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTO1—hematologic cancer	1.51e-05	7.87e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCC3—hematologic cancer	1.51e-05	7.87e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TXN—hematologic cancer	1.51e-05	7.87e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTEN—hematologic cancer	1.51e-05	7.86e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN1B—hematologic cancer	1.51e-05	7.86e-05	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AKT1—hematologic cancer	1.49e-05	7.78e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CASP3—hematologic cancer	1.48e-05	7.7e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SPHK1—hematologic cancer	1.48e-05	7.7e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK8—hematologic cancer	1.48e-05	7.69e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL2—hematologic cancer	1.48e-05	7.69e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AKT1—hematologic cancer	1.47e-05	7.67e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—hematologic cancer	1.47e-05	7.65e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EP300—hematologic cancer	1.44e-05	7.5e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCND1—hematologic cancer	1.44e-05	7.5e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JUN—hematologic cancer	1.44e-05	7.48e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—UGT1A1—hematologic cancer	1.42e-05	7.4e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SRC—hematologic cancer	1.4e-05	7.29e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDKN1A—hematologic cancer	1.39e-05	7.25e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTEN—hematologic cancer	1.39e-05	7.24e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC22A1—hematologic cancer	1.38e-05	7.2e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CRABP1—hematologic cancer	1.38e-05	7.2e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—hematologic cancer	1.36e-05	7.1e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK8—hematologic cancer	1.36e-05	7.08e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AKT1—hematologic cancer	1.36e-05	7.06e-05	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—AKT1—hematologic cancer	1.35e-05	7.04e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—STAT3—hematologic cancer	1.35e-05	7.03e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NRAS—hematologic cancer	1.35e-05	7.02e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALOX5—hematologic cancer	1.35e-05	7.01e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EP300—hematologic cancer	1.33e-05	6.9e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NUP98—hematologic cancer	1.3e-05	6.79e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK3—hematologic cancer	1.29e-05	6.72e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SRC—hematologic cancer	1.29e-05	6.71e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CA—hematologic cancer	1.29e-05	6.7e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ADCY7—hematologic cancer	1.27e-05	6.59e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NCOA3—hematologic cancer	1.27e-05	6.59e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NUP214—hematologic cancer	1.26e-05	6.55e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—hematologic cancer	1.26e-05	6.54e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MYC—hematologic cancer	1.26e-05	6.54e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TGFB1—hematologic cancer	1.25e-05	6.52e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.24e-05	6.48e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—STAT3—hematologic cancer	1.24e-05	6.47e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NRAS—hematologic cancer	1.24e-05	6.46e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCG2—hematologic cancer	1.23e-05	6.42e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MTR—hematologic cancer	1.23e-05	6.42e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ENO2—hematologic cancer	1.21e-05	6.29e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK3—hematologic cancer	1.19e-05	6.18e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTT1—hematologic cancer	1.17e-05	6.1e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KRAS—hematologic cancer	1.16e-05	6.04e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MYC—hematologic cancer	1.16e-05	6.01e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.15e-05	6.01e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TGFB1—hematologic cancer	1.15e-05	6e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SDC1—hematologic cancer	1.15e-05	5.96e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.09e-05	5.7e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.08e-05	5.62e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KRAS—hematologic cancer	1.07e-05	5.56e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CA—hematologic cancer	1.07e-05	5.55e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AKT1—hematologic cancer	1.05e-05	5.48e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.03e-05	5.38e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TP53—hematologic cancer	1.03e-05	5.37e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HRAS—hematologic cancer	9.86e-06	5.13e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CA—hematologic cancer	9.81e-06	5.11e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NQO1—hematologic cancer	9.74e-06	5.07e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CD44—hematologic cancer	9.74e-06	5.07e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	9.54e-06	4.97e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TP53—hematologic cancer	9.49e-06	4.94e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—hematologic cancer	9.44e-06	4.91e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYCS—hematologic cancer	9.22e-06	4.8e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	9.16e-06	4.77e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HRAS—hematologic cancer	9.07e-06	4.72e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKT1—hematologic cancer	8.71e-06	4.53e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—hematologic cancer	8.68e-06	4.52e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.24e-06	4.29e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTP1—hematologic cancer	8.12e-06	4.23e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKT1—hematologic cancer	8.01e-06	4.17e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.86e-06	4.09e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCB1—hematologic cancer	7.69e-06	4e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NCOR1—hematologic cancer	7.47e-06	3.89e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTM1—hematologic cancer	7.47e-06	3.89e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MTHFR—hematologic cancer	6.6e-06	3.44e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.81e-06	3.03e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CG—hematologic cancer	5.54e-06	2.89e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CREBBP—hematologic cancer	5.14e-06	2.68e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CD—hematologic cancer	4.87e-06	2.54e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALB—hematologic cancer	4.81e-06	2.5e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3R1—hematologic cancer	4.6e-06	2.4e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CB—hematologic cancer	4.25e-06	2.21e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTEN—hematologic cancer	3.67e-06	1.91e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—EP300—hematologic cancer	3.5e-06	1.82e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.59e-06	1.35e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKT1—hematologic cancer	2.12e-06	1.1e-05	CbGpPWpGaD
